Cancer survivors find hope in Peer-Led Self-Management program
NCT ID NCT04537195
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a 7-session, peer-led self-management program for 234 cancer survivors who recently finished treatment with curative intent. The program aims to reduce anxiety and depression by teaching symptom management skills in a group setting. Participants are from central Denmark and must have mild to moderate symptoms to join.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
peer-led self-management program
What this could lead to
If it works, this could offer a low-cost, group-based way to help cancer survivors manage anxiety and depression after treatment.
What could go wrong
This is a relatively small, single-region trial with no blinding, so results may not apply broadly. The program is behavioral, not a drug, so effects may be modest.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DEPRESSION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Dep. Oncology, Aarhus University Hospital
Aarhus, 8000, Denmark
-
Dep. Oncology, Regional Hospital West Jutland
Herning, 7400, Denmark